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The impact of renal insufficiency on the outcome of
carotid surgery is influenced by the definition used
Benjamin Kretz, MD,a Nicolas Abello, PhD,b Roger Brenot, MD,a and Eric Steinmetz, PhD,a Dijon, France
Background:Renal insufficiency (RI) seems to be a source of complications after carotid endarterectomy (CEA).However,
published studies do not use a common definition of RI. Our objective was to analyze the effects of RI on carotid surgery
using three classifications of renal function.
Methods:Using a prospective database, we studied renal function and postoperative complications in patients operated on
between January 1, 2003 and December 31, 2008. Renal function was studied using the level of plasma creatinine,
creatinine clearance calculated according to the Cockcroft formula, and to the Modification of Diet in Renal Disease
(MDRD) equation. For each method, the patients were divided into three groups: normal renal function, moderate RI,
and severe RI. The principal judgment criterion was the 30-day non-fatal stroke and death rate.
Results: The analysis concerned 961 CEAs carried out in 901 patients. The 30-day non-fatal stroke and death rate was 2%. In
the analysis of renal function using the level of creatinine, there was no statistical difference between the groups in the 30-day
stroke and death rate (normal renal function: 1.8%, moderate: 2.7%, severe: 8.3%, P  .21). The analysis of renal function
according to creatinine clearance calculated using the Cockcroft formula showed that in the severe RI group, the stroke and
death rate was higher than in the other two groups (normal renal function: 1.7%, moderate RI: 1.4%, severe RI: 7.5%, P 
.004). Analysis using the MDRD formula showed similar differences between the severe RI group and the other two with a
higher rate of 30-day stroke and death (normal renal function: 1.4%, moderate RI: 1.7%, severe RI: 12.5%, P < .001).
Subgroup analysis showed that among patients with severe RI according to the creatinine clearance, those with symptomatic
carotid stenosis had the highest incidences of non-fatal stroke and death (Cockcroft, n  19: 21.1%, MDRD, n  10: 40%).
Conclusion: Severe RI is a risk factor for complications after carotid surgery. Creatinine clearance calculated according to the
MDRD formula correlates most closely with these complications. Symptomatic patients with severe RI, according to the
creatinine clearance, are at high risk with a very high level of postoperative complications. (J Vasc Surg 2010;51:43-50.)Stroke is the third most common cause of death in
industrialized countries and the principal cause of dis-
ability.1 Stenosis of the carotid artery is one of the principal
causes of stroke and is an indication for surgery according
to recommendations based on the NASCET (North Amer-
ican Symptomatic Carotid Endarterectomy Trial),2 ECST
(European Carotid Surgery Trial),3 and ACAS (Asymp-
tomatic Carotid Atherosclerosis Study)4 studies.
The purpose of this preventive surgery is to reduce the
long-term risk of stroke in asymptomatic patients and the
risk of stroke recurrence in symptomatic patients. The risk
of surgery-related morbidity must be lower than the ex-
pected benefits. For this reason, it is important to deter-
mine factors associated with morbidity.
Chronic renal insufficiency is one of the factors stud-
ied and has been the subject of a number of a publications
with contradictory results.5-13 These studies used different
definitions of renal insufficiency (RI). Certain authors used
plasma levels of creatinine to define groups of pa-
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doi:10.1016/j.jvs.2009.08.070tients,5,7,8,10,14 others considered that creatinine clearance
gave a better assessment of renal function,1 and others
associated the two.9 Furthermore, different levels were
used to constitute the groups. On top of this, the method
used to calculate creatinine clearance differed. In most
publications, either the Cockcroft-Gault9 or the Modifica-
tion of Diet in Renal Disease (MDRD)method was used.11
It is therefore difficult to compare the results of these
studies and to determine the stage of renal insufficiency that
may affect the results of carotid surgery.
Our objective was to analyze the influence of renal
insufficiency on our results in carotid surgery and to deter-
mine which method gave the best correlation with postop-
erative complications.
METHODS
Study population. We prospectively gathered in a
database all of the cases of patients operated on for carotid
stenosis in our department from January 1, 2003 to De-
cember 31, 2008. The exclusion criteria were the absence
of a plasma creatinine dosage on the eve of the operation
and dialysis-dependent patients. There were no renal trans-
planted patients in the current series.
The following data were recorded: patients’ character-
istics, cardiovascular risk factors, associated comorbidities,
neurovascular symptoms, surgical data, and postoperative
events up to day 30 (stroke, death, and postoperative
myocardial infarction [MI]). In comorbidities, peripheral
artery disease (PAD) was defined as symptomatic patients
(claudication, critical ischemia) or a history of lower limb
surgery (bypass, angioplasty, percutaneous treatment).
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patient had experienced a neurological ischemic event such
as stroke, transient ischemic attack (TIA), or amaurosis
fugax in the 6 months before the operation.
MI was defined as the presence of an abnormal electro-
cardiogram associated with chest pain and/or elevated
levels of plasma troponin with a value above the 99th
percentile of the upper reference limit.15
Carotid surgery was performed under locoregional an-
esthesia using superficial cervical plexus block, except in the
case of patient refusal, or in the case of combined surgery
(eg, carotid and heart surgery). During the operation, the
cerebral status was monitored by surveillance of the motor
function of the contralateral upper limb (grip-strength
gauge in the contralateral hand or in both hands in cases of
bilateral carotid stenosis  70%) and surveillance of vigi-
lance at 10-minute intervals throughout the intervention
and every 5 minutes while the carotid was clamped. In cases
of intolerance to carotid clamping (loss of consciousness,
agitation, impaired motor function in the upper limb[s]), a
shunt was inserted. Under general anesthesia, a shunt was
systematically inserted. Surgery consisted of open carotid
endarterectomy followed by patch angioplasty (Dacron or
vein) or by a carotid-to-carotid bypass in cases of high
bifurcation. All of the patients were systematically on anti-
platelets, were checked the day after surgery with an ultra-
sound examination, using both continuous wave Doppler
and Duplex, and were usually discharged the same day.
Definitions of RI: We considered three methods to
define RI. To differentiate the groups, we used the levels of
creatinine and creatinine clearance reported in the National
Kidney Foundation practice guidelines.16
- Preoperative level of plasma creatinine:
The patients were put into one of three groups: normal
renal function (level of plasma creatinine  1.5 mg/dL),
moderate RI (1.5 mg/dL  creatinine  3 mg/dL), and
severe RI (creatinine  3 mg/dL).
- Creatinine clearance calculated using the Cockcroft-Gault
formula:17
Creatinine clearance reflects the glomerular filtration
rate (GFR).
The formula used was:
GFR (mL ⁄ min ⁄ 1.73 m2) [(140 age)
 weight k] ⁄ (creatinine in mg ⁄ dL72)
K  1 in men and k  0.85 in women.
- Creatinine clearance calculated using theMDRD formula18
The formula used to calculate the GFR was:
GFR (mL ⁄ min ⁄ 1.73 m2) 186.3
 (creatinine in mg ⁄ dL)1.154 (age)0.203 kk  1 in men and k  0.742 in womenFor these two methods, patients were put into one of
three groups: normal renal function (GFR 60 mL/min),
moderate RI (30 mL/min creatinine 60 mL/min), or
severe RI (creatinine  30 mL/min).
Judgment criteria. The endpoints were the incidence
of neurological events, MI, and death up to day 30 or
during hospitalization in case of prolonged hospital stay.
Neurological events included strokes (neurological deficit
with cerebral lesion on an emergency magnetic resonance
imaging [MRI] or cerebral computed tomography [CT]-
scan) or TIA (neurological deficit with no cerebral lesion,
and resolved in 24h). Diagnoses were confirmed by a
neurologist. The primary endpoint was the 30-day stroke
and death rate defined by the incidence of non-fatal stroke
and death at day 30.
Statistical analysis. The results are presented as
means or medians when the distribution was not Gaussian,
and quantitative data as means  standard deviations [min
max]. For each of the definitions of renal insufficiency, the
three groups were compared in univariate analyses using
the Chi-square test or Fisher’s exact test for categorical
variables, and analysis of variance (ANOVA) for contin-
uous variables. Comparisons were made with the control
group “normal renal function”. Results with P  .05 were
considered significant.
RESULTS
Between January 1, 2003 andDecember 31, 2008, 971
endarterectomies were performed in 911 patients. Ten
patients were excluded from the study because the preop-
erative level of plasma creatinine was missing. The study
thus involved 961 endarterectomies carried out in 901
patients. The proportion of symptomatic stenosis was
25.9% (n 249), among which there were 43.8% of stroke
(n 109), 38.6% of TIA (n 96), and 17.7% of amaurosis
fugax (n  44). The operations were performed under
locoregional anesthesia in 95.8% of cases (n 920). In the
current series, we performed two combined operations
involving carotid and heart surgery (one for coronary artery
bypass graft [CABG], one for aortic valve replacement).
These two patients had moderate renal insufficiency (creat-
inine clearance: 55 mL/min and 37.9 mL/min) and recov-
ery was uneventful.
At day 30, 13 patients (1.3%) had suffered from a
postoperative neurological event (three TIA, 10 strokes).
Six patients recovered completely (after repeat surgery for
thrombosis in two cases). The neurological event was the
cause of death in three patients. We counted these cases as
a stroke and as a death. Four patients kept a minor upper
limb deficit. Nine patients (0.9%) died at day 30. Three
patients with renal insufficiency (moderate insufficiency
according to creatinine level, but severe insufficiency ac-
cording to creatinine clearances) died from postoperative
stroke. Three patients (with normal renal function accord-
ing to creatinine level, but one normal and two with
moderate renal insufficiency according to creatinine levels)
died from postoperative cardiogenic shock linked to MI.
One patient treated with anticoagulation therapy for su-
eath ra
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after a fall the evening following the intervention. One
patient with severe renal insufficiency died at day 13 from
E. coli septicemia originating in the digestive tract. Finally,
one patient treated with anticoagulants died 72 hours after
the intervention from suffocating hematoma. Seven pa-
tients (0.7%) sufferedMI. The 30-day stroke and death rate
was 2%.
Study of renal function according to plasma
creatinine. The characteristics of the three groups of
patients are presented in Table I. Eight hundred patients
(83%) had normal preoperative renal function; 149 pa-
tients had moderate RI (16%), while 12 patients (1%)
had severe RI.
Patients in the moderate and severe RI groups were
older than those in the control group, and PAD was more
frequent in the severe RI group (P  .001).
The incidence of postoperative neurological events was
1.1% in the control group (n 9), 2.7% in the moderate RI
group (n  4), and 0% in the severe RI group (P  .29).
The incidence of postoperative death was 0.6% in the
control group (n  5), 2% in the moderate RI group (n 
3), and 8.3% (n 1) in the severe RI group (P .01). The
incidence of postoperative MI was 0.6% in the control
group (n 5), 1.3% in the moderate RI group (n 2), and
Table I. Analysis according to level of plasma creatinine
Renal function a
Normal renal function M
creatinine  1.5 mg/dL 1.5 mg
No. (%)
No. of patients 800 (83.2%)
Cardiovascular risk factors
Smoking 463 (57.9%)
Hypertension 600 (75.0%)
Dyslipidemia 478 (59.8%)
Diabetes 223 (27.9%)
BMI  30 158 (19.8%)
Gender (male) 597 (74.6%)
Age (mean) 71.7 years  9.3
Age  80 years old 170 (21.3%)
Weight (mean) 75 kg  13.8
Medical history
COPD 25 (3.1%)
Coronaropathy 278 (34.8%)
PAD 181 (22.6%)
Controlateral occlusion 53 (6.6%)
Symptomatic patients 215 (26.9%)
Stroke 91 (11.4%)
TIA 84 (1.5%)
Amaurosis fugax 40 (5.0%)
Surgery
Peroperative shunt 64 (8.0%)
30-day morbi-mortality
Neurological event 9 (1.1%)
Death 5 (0.6%)
Myocardial infarction 5 (0.6%)
Stroke and death 1.8%
BMI, Body mass index; COPD, chronic obstructive pulmonary disease; PA
Stroke and death rate: Non-fatal neurological events (TIA or stroke) and d0% in the severe RI group (P  .61).The stroke and death rate was 1.8% in the control
group, 2.7% in the moderate RI group, and 8.3% in the
severe RI group (P  .21).
Study of renal function using creatinine clearance
calculated according to the Cockcroft-Gault formula.
The characteristics of the three groups of patients are
shown in Table II. Normal preoperative renal function was
found in 480 patients (50%), moderate RI was found in 414
patients (43%), and severe RI in 67 patients (7%).
Smoking was less frequent in the moderate RI (46.9%)
and severe RI (43.3%) groups than in the control group
(68.5%) (P .001). In parallel, the moderate RI and severe
RI groups contained a lower proportion of diabetics (P 
.01) and obese patients (P  .001) than did the control
group. The use of shunts was greater in the moderate RI
(10%) and severe RI (16%) groups than in the control
group (6%) (P  .01)
The incidence of postoperative neurological events was
1.3% in the control group (n 6), 0.7% in the moderate RI
group (n 3), and 6% in the severe RI group (n 4) (P
.01). The incidence of postoperative death was 0.4% in the
control group (n 2), 0.7% in the moderate RI group (n
3), and 6% (n 4) in the severe RI group (P .001). The
incidence of MI was 0.6% in the control group (n  3),
0.7% in the moderate RI group (n  3), and 1.5% in the
ing to plasma creatinine (n  961)
P value
te renal insufficiency Severe renal insufficiency
creatinine  3 mg/dL creatinine  3 mg/dL
No. (%) No. (%)
149 (15.5%) 12 (1.2%)
81 (54.4%) 8 (66.7%) .589
126 (84.6%) 10 (83.3%) .035
77 (51.7%) 9 (75.0%) .095
41 (27.5%) 5 (41.7%) .567
26 (17.4%) 3 (25.0%) .718
125 (83.9%) 9 (75.0%) .051
years  7.7 75 years  6.0 .001
48 (32.2%) 2 (16.7%) .012
76 kg  13.4 78 kg  16.0 .520
8 (5.4%) 0 (0.0%) .310
60 (4.3%) 7 (58.3%) .115
56 (37.6%) 5 (41.7%) .001
11 (7.4%) 0 (0.0%) .750
32 (21.5%) 2 (16.7%) .294
17 (11.4%) 1 (8.3%)
11 (7.4%) 1 (8.3%)
4 (2.7%) 0 (.0%)
14 (9.4%) 3 (25.0%) .980
4 (2.7%) 0 (.0%) .293
3 (2.0%) 1 (8.3%) .008
2 (1.3%) 0 (0.0%) .612
2.7% 8.3% .210
ipheral artery disease; TIA, transient ischemic attack.
te.ccord
odera
/dL 
76
D, persevere RI group (n  1) (P  .74).
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group, 1.4% in the moderate RI group, and 7.5% in the
severe RI group (P  .004).
Study of renal function according to creatinine
clearance calculated using the MDRD formula. The
characteristics of the three groups of patients are presented
in Table III. Normal preoperative renal function was found
in 574 patients (60%), moderate RI in 347 patients (36%),
and severe RI in 40 patients (4%).
The moderate RI and severe RI groups comprised a
lower proportion of smokers (P  .001) but more hyper-
tensive patients (P  .001) than in the control group.
Coronary artery disease or PAD was more frequent in the
severe RI group (57.5% and 45%, respectively) than in the
other groups (P  .01).
Shunts were used more frequently in the severe RI
group (25%) than in the moderate RI (8%) and control
(7%) groups (P  .01).
The incidence of postoperative neurological events was
1% in the control group (n  6), 0.9% in the moderate RI
group (n 3), and 10% in the severe RI group (n 4) (P
.001). The incidence of postoperative death was 0.3% in the
control group (n 2), 0.9% in the moderate RI group (n
3), and 10% (n 4) in the severe RI group (P .001). The
Table II. Analysis according to creatinine clearance calcul
Renal function according
Normal renal function Mo
GFR  60 mL/min 60 mL
No. (%)
No. of patients 480 (49.9%)
Cardiovascular risk factors
Smoking 329 (68.5%)
Hypertension 346 (72.1%)
Dyslipidemia 297 (61.9%)
Diabetes 158 (32.9%)
BMI  30 134 (27.9%)
Gender (male) 414 (86.3%)
Age (mean) 67.5 years  8.6
Age  80 years old 30 (6.3%)
Weight (mean) 80.7 kg  13.0
Medical history
COPD 13 (2.7%)
Coronaropathy 165 (34.4%)
PAD 119 (24.8%)
Controlateral occlusion 28 (5.8%)
Symptomatic patients 136 (28.3%)
Stroke 57 (11.9%)
TIA 49 (10.2%)
Amaurosis fugax 30 (6.3%)
Surgery
Peroperative shunt 28 (5.8%)
30-day morbi-mortality
Neurological event 6 (1.3%)
Death 2 (0.4%)
Myocardial infarction 3 (0.6%)
Stroke and death 1.7%
BMI, Body mass index; COPD, chronic obstructive pulmonary disease; PA
Stroke and death rate: Non-fatal neurological events (TIA or stroke) and dincidence of MI was 0.5% in the control group (n  3),1.2% in the moderate RI group (n  4), and 0% in the
severe RI group (P  .48).
The stroke and death rate was 1.4% in the control
group, 1.7% in the moderate RI group, and 12.5% in the
severe RI group (P  .001).
Fig 1 compares the stroke and death rate in the differ-
ent groups according to the classification used. For patients
with normal renal function, whatever the classification
used, the incidence is around 1.7%. For all of the classifica-
tions, the stroke and death rate increases with the severity of
the renal function impairment but to different degrees. The
stroke and death rate in patients with severe RI according to
the MDRD classification is 12.5%, whereas it is 7.5% if the
Cockcroft classification is used and 8.3% if creatininemia is
the yardstick.
One subgroup studywas carried out.Within the severeRI
groups according to Cockcroft and MDRD, we analyzed the
impact of preoperative neurovascular symptoms on the inci-
dence of death and neurological events (Table IV). In these
two groups, symptomatic patients were more likely to die
after the operation (P  .01). Symptomatic patients with
severe renal insufficiency according to the MDRD classifi-
cation were more likely to suffer from postoperative stroke
than were asymptomatic patients (30% vs. 3.3%; P  .04).
using the Cockcroft-Gault formula
tinine clearance using the Cockcroft formula
P value
e renal insufficiency Severe renal insufficiency
 GFR  30 mL/min GFR  30 mL/min
No. (%) No. (%)
14 (43.1%) 67 (7.0%)
94 (46.9%) 29 (43.3%) .001
34 (80.7%) 56 (83.6%) .001
36 (57.0%) 31 (46.3%) .034
94 (22.7%) 17 (25.4%) .001
47 (11.4%) 6 (9.0%) .001
80 (67.6%) 37 (55.2%) .001
9 years  6.7 79.8 years  7.6 .001
55 (37.4%) 35 (52.2%) .001
0.6 kg  12.0 65.0 kg  13.6 .001
17 (4.1%) 3 (4.5%) .460
51 (36.5%) 29 (43.3%) .340
98 (23.7%) 25 (37.3%) .056
31 (7.5%) 5 (7.5%) .740
94 (22.7%) 19 (28.4%) .143
42 (10.1%) 10 (14.9%)
39 (9.4%) 8 (11.9%)
13 (3.1%) 1 (1.5%)
42 (10.1%) 11 (16.4%) .001
3 (0.7%) 4 (6.0%) .001
3 (0.7%) 4 (6.0%) .001
3 (0.7%) 1 (1.5%) .740
1.4% 7.5% .004
ipheral artery disease; TIA, transient ischemic attack.
te.ated
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death was 0%, and the incidence of postoperative stroke was
2.1% (Cockcroft) and 3.3% (MDRD). For all asymptomatic
RI patients taken together, the stroke and death rate was
2.1% and 3.3% according to the Cockcroft and MDRD
classification, respectively. The stroke and death rate in
symptomatic severe RI patients was significantly higher:
21.1% for the Cockcroft classification (P .02) and 40% for
Table III. Analysis according to creatinine clearance calcu
Renal function according
Normal renal function Mo
GFR  60 mL/min 60 mL
No. (%)
No. of patients 574 (59.7%)
Cardiovascular risk factors
Smoking 360 (62.7%)
Hypertension 402 (70.0%)
Dyslipidemia 344 (59.9%)
Diabetes 166 (28.9%)
BMI  30 116 (20.2%)
Gender (male) 472 (82.2%)
Age (mean) 70.1 years  9.5
Age  80 years old 95 (16.6%)
Weight (mean) 76 kg  13.8
Medical history
COPD 19 (3.3%)
Coronaropathy 200 (34.8%)
PAD 128 (22.3%)
Controlateral occlusion 37 (6.4%)
Symptomatic patients 158 (27.5%)
Stroke 66 (11.5%)
TIA 64 (11.1%)
Amaurosis fugax 28 (4.9%)
Surgery
Peroperative shunt 42 (7.3%)
30-day morbi-mortality
Neurological event 6 (1.0%)
Death 2 (0.3%)
Myocardial infarction 3 (0.5%)
Stroke and death 1.4%
BMI, Body mass index; COPD, chronic obstructive pulmonary disease; MD
transient ischemic attack.
Stroke and death rate: Non-fatal neurological events (TIA or stroke) and d
Fig 1. Thirty-day non fatal stroke and death rate according to
renal function and definition used. NS, Non-significant.the MDRD classification (P  .01).DISCUSSION
In the light of these results, it appears that renal insuf-
ficiency has an impact on the results of carotid surgery. The
incidence of postoperative complications correlates with
the severity of the renal insufficiency. By analyzing the
incidence of complications according to renal function
assessed using three different classification methods, we
were able to show the impact of RI depending on the
classification method used. RI assessed using MDRD cre-
atinine clearance gives the highest incidence of complica-
tions and probably provides the best indication of the
gravity of this disease. It also appears that the presence of
preoperative neurovascular symptoms in these patients
must be taken into account when deciding whether surgery
is indicated. Therefore, although it is appropriate to con-
sider carotid surgery in asymptomatic RI patients, whatever
the severity of RI, the operation may be inappropriate in
patients with severe RI and symptoms of neurovascular
disease. Indeed, the incidence of complications in this
group of patients is far higher than the maximum recom-
mended in the literature,2-4,19,20 and the expected benefits
of the operation are outweighed by the severe morbidity.
Several studies have tried to define the relationship
using the MDRD formula
atinine clearance using the MDRD formula
P value
e renal insufficiency Severe renal insufficiency
 GFR  30 mL/min GFR  30 mL/min
No. (%) No. (%)
47 (36.1%) 40 (4.2%)
72 (49.6%) 20 (50.0%) .001
99 (86.2%) 35 (87.5%) .001
00 (57.6%) 20 (50.0%) .411
90 (25.9%) 13 (32.5%) .501
63 (18.2%) 8 (20.0%) .742
36 (68.0%) 23 (57.5%) .001
9 years  7.4 76.7 years  7.2 .001
12 (32.3%) 13 (32.5%) .001
4.4 kg  13.6 72.6 kg  14.1 .109
13 (3.7%) 1 (2.5%) .892
22 (35.2%) 23 (57.5%) .014
96 (27.7%) 18 (45.0%) .001
25 (7.2%) 2 (5.0%) .521
81 (23.3%) 10 (25.0%) .370
36 (10.4%) 7 (17.5%)
29 (8.4%) 3 (7.5%)
16 (4.6%) 0 (0.0%)
29 (8.4%) 10 (25.0%) .001
3 (0.9%) 4 (10.0%) .001
3 (0.9%) 4 (10.0%) .001
4 (1.2%) 0 (0.0%) .483
1.7% 12.5% .001
odification of Diet in Renal Disease; PAD, peripheral artery disease; TIA,
te.lated
to cre
derat
/min
3
1
2
2
2
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1
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RD, mbetween RI and the complications of carotid surgery.
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using plasma creatinine for 285 interventions in 237 pa-
tients. For the combined endpoint of postoperative stroke
and death, they found an incidence of 43% in the severe RI
group (n 7, creatinine 2.9 mg/dL) compared with 7%
in the control group (n  264, creatinine  1.5 mg/dL)
(P  .001).
In 497 patients separated according to the level of
creatininemia  1.8 mg/dL (n  448) or  1.8 mg/dL
(n  49), Ayerdi et al14 reported an incidence of MI of
5.4% and 28.6%, an incidence of postoperative stroke of
2.7% and 2.0%, and mortality of 0.9% and 8.2%, respec-
tively, thus confirming the negative impact of RI on the
results of carotid surgery.
Reil et al7 reviewed 370 endarterectomies with regard to
RI defined by creatinine  1.5 mg/dL and found no differ-
ence between the groups for postoperative stroke and death.
Reed et al21 reported 1370 endarterectomies and ana-
lyzed different suspected risk factors including RI. There
was no difference between the RI group defined by creati-
nine  2 mg/dL and the control group with regard to
postoperative stroke and death.
Ascher et al8 analyzed 675 interventions in 609 pa-
tients, 166 patients with RI (creatinine 1.5 mg/dL), and
443 control patients. There was no difference between the
groups for postoperative strokes (1.2% in the RI group vs
0.5% in the control group). Mortality, however, was 3% in
the RI group and 0% in the control group (P  .002).
Subgroup analysis of patients with renal insufficiency
showed a mortality of 0.7% in patients with moderate RI
(creatinine  2.9 mg/dL) and 17% in cases of severe RI
(creatinine  3 mg/dL) (P  .001). In patients with
creatinine  3 mg/dL, mortality in symptomatic patients
was greater than that in asymptomatic patients, but the
difference was not significant (28% vs 13%, P  .6). The
authors recommended not proposing carotid surgery to
patients with severe RI.
Tarakji et al10 reviewed 1351 interventions, separating
patients with renal insufficiency into two groups: moderate
RI and severe RI (creatinine thresholds: 1.5 mg/dL and 3
mg/dL, respectively). The incidence of a combined end-
Table IV. Impact of preoperative neurological symptoms
Severe RI according to Coc
N  67
Stroke/death rate 7.5%
Asymptomatic Symptomatic
No. of patients 48 (71.6%) 19 (28.4%)
30-day morbi-mortality
Neurological event 1 (2.1%) 3 (15.8%)
Death 0 (0.0%) 4 (21.1%)
Stroke/death rate 2.1% 21.1%
MDRD, Modification of Diet in Renal Disease; RI, renal insufficiency.point postoperative stroke and death was 9% for all RItogether (n  143) (7.3% in moderate RI, 19% in severe
RI) and 2.6% in the control group (n  150) (P  .05).
Debing et al9 analyzed the impact of renal function for
1011 endarterectomies in 857 patients classified into RI
patients (n  102, creatinine  1.5 mg/dL and creatinine
clearance  30 mL/min) and a control group (n  909).
The incidence of postoperative death was higher in the RI
group than in the control group (3.9% vs 1%, P  .013).
The largest study was that done by Sidawy et al,11 who
used the Veterans Affairs Medical Center database to ana-
lyze the results of 20,899 carotid endarterectomies. Renal
function was assessed using creatinine clearance calculated
using theMDRD formula, and patients were separated into
moderate RI (n  6423, GFR 30 mL/min/1.73 m2-59
mL/min/1.73 m2) and severe RI (n  511, GFR  30
mL/min/1.73 m2). The two groups were matched for
neurovascular symptomatology, but symptomatic patients
were defined as those who had had preoperative stroke or
TIA, whatever the time between the symptom and the
operation. There was a significant difference between the
groups for postoperative stroke (control 1.7%, moderate RI
1.9%, severe RI 2.7%). The incidence of heart complica-
tions (MI or cardiac arrest) was highest in the moderate RI
group (P  .001). This was found in our study, but the
relationship was not significant. Severe RI patients pre-
sented higher mortality rates (3% vs control 1%, P .001).
Our results are in keeping with the above, and we also
showed that RI, especially when creatinine clearance calcu-
lated by the Cockcroft or MDRD formula was below 30
mL/min/1.73 m2, was an independent risk factor for
postoperative complications.
The negative impact of RI has also been highlighted in
other types of surgery, especially heart22,23 and subrenal
aortic surgery for which it has been shown that creatinine
clearance was a stronger predictor of complications than
was plasma creatinine alone24 and for lower extremity
bypass surgery.25
Several factors may explain the higher incidence of
postoperative complications in patients with renal insuffi-
ciency. Cardiovascular disease is the principal cause of death
in patients on dialysis.26 There is a relationship between RI
tients with severe RI
Severe RI according to MDRD
N  40
12.5%
P value Asymptomatic Symptomatic P value
30 (75.0%) 10 (25.0%)
.075 1 (3.3%) 3 (30.0%) .041
.005 0 (0.0%) 4 (40.0%) .002
.021 3.3% 40% .012in pa
kcroftand heart failure, called the cardio-renal syndrome, which is
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glish men with moderate renal insufficiency, there was an
excess risk of stroke of 60% and a correlation between the
incidence ofMI, stroke, and death caused by cardiovascular
disease that was proportional to the level of plasma creati-
nine.28
The terms calciphylaxis or calcifying uremic arteriolopa-
thy were proposed to describe more precisely a rapidly
progressive form of calcification of the tunica media in
patients with renal insufficiency.29 The negative impact of
RI on the results of carotid surgery probably stems from
diffuse microangiopathic lesions caused by RI, which lead
to postoperative MI, or the failure of limb revascularization
in PAD.30
In this study, we have shown that analysis of the results
following carotid surgery may vary depending on the
method used to assess renal function. Our objective was not
to determine what value best reflects true renal function but
rather what value is the best predictor of postoperative
complications. It appears that plasma creatinine is not only
a poor predictor of renal function,11 as it depends on a
number of factors (age, gender, race, method of measure-
ment), but it is above all a poor predictor of postoperative
complications.
The results reported in Table IV concerning severe RI
patients raised several questions: the postoperative compli-
cation rate is tremendously high in the symptomatic group
and surprisingly low in the asymptomatic group. Two
criticisms can be stated here. First, none of the groups had
a “medical-alone” control group to be compared with (ie,
what is the risk of stroke in symptomatic as well as asymp-
tomatic patients with severe carotid stenosis and severe RI
who are not operated on?). So, is difficult to draw any
conclusions about the indications for surgery in these spe-
cific cases. Second, the small number of patients in each
group is a source of error. The only published data con-
cerning a large number of patients came from the VA study
and showed that a history of stroke or TIA before CEA was
an independent predictor of increased neurologic events
and death. The subgroup “symptomatic stenosis and severe
RI” was not specifically studied in the VA series. Therefore,
the data shown in Table IV need to be confirmed in a larger
group of patients, which may address the question as to
whether or not this high-risk subgroup would benefit from
surgery. Subsequently, carotid artery stenting could be
tested as an alternative to surgery in this population.
CONCLUSION
We have shown that RI defined by creatinine clearance
calculated according to theMDRD formula correlates most
strongly with the risk of postoperative complications fol-
lowing carotid surgery. Patients with symptomatic carotid
stenosis and severe RI present a very high risk of postoper-
ative complications, and the interest of preventive carotid
surgery in this group of patients needs to be considered very
carefully.
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